282 related articles for article (PubMed ID: 9140559)
1. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.
Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ
Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559
[TBL] [Abstract][Full Text] [Related]
2. Influence of two diets on pharmacokinetic parameters of allopurinol and oxypurinol in healthy beagles.
Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M
Am J Vet Res; 1997 May; 58(5):511-5. PubMed ID: 9140560
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
Mills PC; Dunnett M; Smith NC
J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
Graham S; Day RO; Wong H; McLachlan AJ; Bergendal L; Miners JO; Birkett DJ
Br J Clin Pharmacol; 1996 Apr; 41(4):299-304. PubMed ID: 8730975
[TBL] [Abstract][Full Text] [Related]
6. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
7. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of allopurinol-containing tablet preparations.
Barthel W; Hüller G; Haustein KO
Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763
[TBL] [Abstract][Full Text] [Related]
10. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
11. Placental transfer and pharmacokinetics of allopurinol in late pregnant sows and their fetuses.
van Dijk AJ; Parvizi N; Taverne MA; Fink-Gremmels J
J Vet Pharmacol Ther; 2008 Dec; 31(6):489-95. PubMed ID: 19000269
[TBL] [Abstract][Full Text] [Related]
12. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
Fenner H; Schiemann O; Gikalov I
Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
[TBL] [Abstract][Full Text] [Related]
13. Effects of time and dilution on concentration of xanthine in frozen urine and plasma of dogs.
Bartges JW; Osborne CA; Felice LJ; Chen M; Ulrich LK
Am J Vet Res; 1997 Feb; 58(2):118-20. PubMed ID: 9028471
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of thiamphenicol in dogs.
Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary fat on oral bioavailability of tepoxalin in dogs.
Homer LM; Clarke CR; Weingarten AJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):287-91. PubMed ID: 15953202
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
[TBL] [Abstract][Full Text] [Related]
19. Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.
Walter-Sack I; de Vries JX; Ernst B; Frei M; Kolb S; Kosmowski J; Priebe U; Schroder HE; Slotty C; Voss A; Weber A; Wegscheider K
J Rheumatol; 1996 Mar; 23(3):498-501. PubMed ID: 8832991
[TBL] [Abstract][Full Text] [Related]
20. Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs.
Flory AB; Rassnick KM; Balkman CE; Kiselow MA; Autio K; Beaulieu BB; Lewis LD
Am J Vet Res; 2008 Oct; 69(10):1316-22. PubMed ID: 18828689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
